Compounds > phenoxan
Page last updated: 2024-12-11

phenoxan

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

phenoxan: structure given in first source; isolated from Polyangium; inhibits electron transport at NADH-ubiquinone oxidoreductase; do not confuse this with phenoxan given as synonym for FENDILENE [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5467345
CHEMBL ID2004336
SCHEMBL ID19717663
MeSH IDM0208386

Synonyms (15)

Synonym
nsc-650914
134332-63-1
phenoxan
5-ethyl-2-methoxy-3-methyl-6-[2-[(e)-3-methyl-4-phenyl-but-3-enyl]oxazol-4-yl]pyran-4-one
nsc650914
4h-pyran-4-one, 3-ethyl-6-methoxy-5-methyl-2-[2-[(3e)-3-methyl-4-phenyl-3-butenyl]-4-oxazolyl]-
5-ethyl-2-methoxy-3-methyl-6-[2-[(e)-3-methyl-4-phenylbut-3-enyl]-1,3-oxazol-4-yl]pyran-4-one
4h-pyran-4-one, 3-ethyl-6-methoxy-5-methyl-2-(2-((3e)-3-methyl-4-phenyl-3-butenyl)-4-oxazolyl)-
nsc 650914
3-ethyl-6-methoxy-5-methyl-2-(2-((3e)-3-methyl-4-phenyl-3-butenyl)-4-oxazolyl)-4h-pyran-4-one
4h-pyran-4-one, 3-ethyl-6-methoxy-5-methyl-2-(2-(3-methyl-4-phenyl-3-butenyl)-4-oxazolyl)-, (e)-
5-ethyl-2-methoxy-3-methyl-6-(2-((e)-3-methyl-4-phenyl-but-3-enyl)oxazol-4-yl)pyran-4-one
CHEMBL2004336
4h-pyran-4-one,3-ethyl-6-methoxy-5-methyl-2-[2-[(3e)-3-methyl-4-phenyl-3-buten-1-yl]-4-oxazolyl]-
SCHEMBL19717663
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (3)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.84

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.84 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.84)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
oxazoles
Oxazoles: Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions.. 1,3-oxazole : A five-membered monocyclic heteroarene that is an analogue of cyclopentadiene with O in place of CH2 at position 1 and N in place of CH at position 3.. oxazole : An azole based on a five-membered heterocyclic aromatic skeleton containing one N and one O atom.		2.68301,3-oxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
glycosides
[no description available]		210
aureothin
aureothin: isolated from culture MA-2465; structure. aureothin : A C-nitro compound that is (3Z)-3-[(2E)-2-methyl-3-(4-nitrophenyl)prop-2-en-1-ylidene]tetrahydrofuran which is substituted by a 6-methoxy-3,5-dimethyl-4-oxo-4H-pyran-2-yl group at position 5. It is isolated from the soil bacterium, Streptomyces thioluteus and exhibits antitumor, antifungal, and insecticidal activities.		2104-pyranones;
C-nitro compound;
ketene acetal;
olefinic compound;
oxolanes		antibacterial agent;
antifungal agent;
antineoplastic agent;
antiparasitic agent;
bacterial metabolite;
EC 1.6.5.3 [NADH:ubiquinone reductase (H(+)-translocating)] inhibitor
ribose
ribopyranose : The pyranose form of ribose.		210D-ribose;
ribopyranose
ConditionIndicatedRelationship StrengthStudiesTrials
Cancer of Ovary
[description not available]		01.9910
Ovarian Neoplasms
Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.		01.9910